Compare Yomeishu Seizo Co., Ltd. with Similar Stocks
Dashboard
1
Poor Management Efficiency with a low ROE of 2.04%
- The company has been able to generate a Return on Equity (avg) of 2.04% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of -0.90% over the last 5 years
3
Flat results in Dec 25
4
With ROE of 1.53%, it has a expensive valuation with a 1.09 Price to Book Value
Stock DNA
Pharmaceuticals & Biotechnology
JPY 71,610 Million (Small Cap)
72.00
NA
0.00%
-0.16
1.74%
1.51
Revenue and Profits:
Net Sales:
2,647 Million
(Quarterly Results - Dec 2025)
Net Profit:
191 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-8.47%
0%
-8.47%
6 Months
5.74%
0%
5.74%
1 Year
57.53%
0%
57.53%
2 Years
115.54%
0%
115.54%
3 Years
118.92%
0%
118.92%
4 Years
129.98%
0%
129.98%
5 Years
109.52%
0%
109.52%
Yomeishu Seizo Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-0.90%
EBIT Growth (5y)
-26.52%
EBIT to Interest (avg)
45.05
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.12
Sales to Capital Employed (avg)
0.22
Tax Ratio
30.22%
Dividend Payout Ratio
91.69%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.90%
ROE (avg)
2.04%
Valuation key factors
Factor
Value
P/E Ratio
72
Industry P/E
Price to Book Value
1.09
EV to EBIT
348.37
EV to EBITDA
53.84
EV to Capital Employed
1.11
EV to Sales
4.46
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
0.32%
ROE (Latest)
1.53%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
Dec'25
Dec'24
Change(%)
Net Sales
2,647.50
3,014.70
-12.18%
Operating Profit (PBDIT) excl Other Income
208.10
238.70
-12.82%
Interest
0.00
6.40
-100.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
190.60
186.30
2.31%
Operating Profit Margin (Excl OI)
0.80%
9.60%
-0.88%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2025 is -12.18% vs -1.96% in Dec 2024
Consolidated Net Profit
YoY Growth in quarter ended Dec 2025 is 2.31% vs -44.14% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
Mar'25
Mar'24
Change(%)
Net Sales
10,017.30
10,242.20
-2.20%
Operating Profit (PBDIT) excl Other Income
845.00
1,041.40
-18.86%
Interest
26.60
24.10
10.37%
Exceptional Items
-39.30
-0.00
Consolidate Net Profit
679.60
952.80
-28.67%
Operating Profit Margin (Excl OI)
12.80%
46.30%
-3.35%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2025 is -2.20% vs -3.80% in Mar 2024
Consolidated Net Profit
YoY Growth in year ended Mar 2025 is -28.67% vs -6.64% in Mar 2024
About Yomeishu Seizo Co., Ltd. 
Yomeishu Seizo Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






